LAHCF | Health Care Fund | Lord Abbett
Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Health Care Fund

Summary

Summary

What is the Health Care Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of companies within the health care sector.

Fund Basicsas of 08/31/2021

Total Net Assets
$7.58 M
Inception Date
08/01/2019
Dividend Frequency
Monthly (Daily Accrual)
Number of Holdings
84
Minimum Initial Investment
$1,500+

Expense Ratioas of 08/31/2021

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge 11.48% 30.88% - - - 27.15%
Lipper Category Avg. Health/Biotechnology Funds 10.63% 26.06% - - - -
MSCI ACWI Health Care Index (Net) 16.04% 22.68% - - - 21.93%
w/ sales charge 5.08% 23.38% - - - 23.57%

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge 5.28% 34.10% - - - 26.02%
Lipper Category Avg. Health/Biotechnology Funds 6.76% 27.59% - - - -
MSCI ACWI Health Care Index (Net) 9.86% 23.48% - - - 20.56%
w/ sales charge -0.77% 26.41% - - - 22.17%

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

INVESTMENT TEAM

Devesh Karandikar
Devesh Karandikar

Portfolio Manager & Research Analyst

25 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Heidi A. Lawrence
Heidi A. Lawrence

Portfolio Manager

20 Years of Industry Experience

Samantha E. Shevins
Samantha E. Shevins

Portfolio Manager

21 Years of Industry Experience

Supported By 19 Investment Professionals with 34 Years Avg. Industry Experience

Contact a Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge 11.48% 30.88% - - - 27.15%
Lipper Category Avg. Health/Biotechnology Funds 10.63% 26.06% - - - -
MSCI ACWI Health Care Index (Net) 16.04% 22.68% - - - 21.93%
w/ sales charge 5.08% 23.38% - - - 23.57%

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge 5.28% 34.10% - - - 26.02%
Lipper Category Avg. Health/Biotechnology Funds 6.76% 27.59% - - - -
MSCI ACWI Health Care Index (Net) 9.86% 23.48% - - - 20.56%
w/ sales charge -0.77% 26.41% - - - 22.17%

Fund Expense Ratio :

Gross 6.30%

Net 1.03%

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Details as of 08/31/2021

Total Net Assets
$7.58 M
Number of Holdings
84
Weighted Average Market Cap.
110.4 B
P/B Ratio
7.2x
P/E Ratio
29.0x

Attribution Analysis 

Health Care Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Contributors & Detractors as of  06/30/2021

Contributors

Holding Contribution
Eli Lilly & Co. 0.9%
Intellia Therapeutics I 0.6%
Danaher Corp. 0.6%
AstraZeneca PLC 0.6%
IDEXX Laboratories 0.5%

Detractors

Holding Contribution
Curis Inc -0.4%
Tg Therapeutics Inc -0.3%
Insmed Inc -0.2%
Orchard Therapeutics Pl -0.2%
Chemocentryx Inc -0.2%

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 09/24/2021

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $50,000 5.75% 5.00% $22.91
$50,000 to $99,999 4.75% 4.00% $22.67
$100,000 to $249,999 3.95% 3.25% $22.48
$250,000 to $499,999 2.75% 2.25% $22.20
$500,000 to $999,999 1.95% 1.75% $22.02
$1,000,000 to $5,000,000 0.00% 1.00% $21.59

Expense Ratioas of 08/31/2021

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field